Clinical trials
Phase 1/2 Respiratory Syncytial Virus Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi Pasteur, a Sanofi Company | 4 |
| GlaxoSmithKline | 3 |
| Ab&B Bio-tech Co., Ltd.JS | 1 |
| Ablynx, a Sanofi company | 1 |
| Blue Lake Biotechnology Inc. | 1 |
| Clover Biopharmaceuticals AUS Pty | 1 |
| Hangzhou Sciwind Biosciences Co., Ltd. | 1 |
| MedImmune LLC | 1 |
| PEACHES BIOTECH | 1 |
| Pulmocide Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Syncytial Virus Infections | 17 |
| COVID-19 | 1 |
| Cytokine Release Syndrome | 1 |
| Influenza, Human | 1 |
| Lung Diseases | 1 |
| Paramyxoviridae Infections | 1 |
| Pneumonia | 1 |
| Respiratory Distress Syndrome | 1 |
| Systemic Inflammatory Response Syndrome | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.